Azopt is a drug owned by Sandoz Inc. It is protected by 3 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 24, 2013. Details of Azopt's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
|
US5461081 (Pediatric) | Topical ophthalmic pharmaceutical vehicles |
Apr, 2013
(11 years ago) |
Expired
|
| US5461081 | Topical ophthalmic pharmaceutical vehicles |
Oct, 2012
(12 years ago) |
Expired
|
|
US5378703 (Pediatric) | Sulfonamides useful as carbonic anhydrase inhibitors |
Oct, 2012
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Azopt is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Azopt's family patents as well as insights into ongoing legal events on those patents.
Azopt's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Azopt's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 24, 2013 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Azopt Generic API suppliers:
Brinzolamide is the generic name for the brand Azopt. 3 different companies have already filed for the generic of Azopt, with Bausch And Lomb having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Azopt's generic
Alternative Brands for Azopt
Azopt which is used for various methods of delivering the drug to the patient., has several other brand drugs using the same active ingredient (Brinzolamide). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Alcon Labs Inc |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Brinzolamide, Azopt's active ingredient. Check the complete list of approved generic manufacturers for Azopt
About Azopt
Azopt is a drug owned by Sandoz Inc. It is used for various methods of delivering the drug to the patient. Azopt uses Brinzolamide as an active ingredient. Azopt was launched by Sandoz in 1998.
Approval Date:
Azopt was approved by FDA for market use on 01 April, 1998.
Active Ingredient:
Azopt uses Brinzolamide as the active ingredient. Check out other Drugs and Companies using Brinzolamide ingredient
Treatment:
Azopt is used for various methods of delivering the drug to the patient.
Dosage:
Azopt is available in suspension/drops form for ophthalmic use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 1% | SUSPENSION/DROPS | Prescription | OPHTHALMIC |